Michael Catlin - 05 Oct 2023 Form 4 Insider Report for Kiromic Biopharma, Inc. (KRBPQ)

Role
Director
Signature
/s/ Michael Catlin
Issuer symbol
KRBPQ
Transactions as of
05 Oct 2023
Net transactions value
$0
Form type
4
Filing time
06 Oct 2023, 16:06:21 UTC
Previous filing
10 Aug 2023
Next filing
20 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRBP Restricted Stock Units Award $0 +7,500 $0.000000 7,500 05 Oct 2023 Common Stock 7,500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU.